As an example, NADPH-oxidase or PAD4 knock-out mice develop lupus-like disorders which contradict the studies that suggested improvement in the case of administration of NADPH-oxidase or PAD4 inhibitors in NET-related autoimmune diseases (56). Here, FMO5 is linked to autoimmune disease.